Project Grant R43GM154597

Award Date 5/1/24
Completion Date 4/30/25
Dollars Obligated $296K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is providing $275,000 to Dinya DNA Inc. to support the commercial development of a novel DNA synthesis technology. The key products or services being delivered include: Developing new methods to ensure higher fidelity DNA precursors, which are the building blocks for DNA synthesis Reducing synthesis costs by streamlining the DNA synthesis...
The National Institute of General Medical Sciences (NIGMS) awarded a $394,857 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Nebraska to develop a system to protect and concentrate large DNA molecules for genome analysis. The project aims to: Develop an inverted insert to protect DNA during cell lysis, and Develop a roadblock to concentrate chromosomal DNA. This innovative approach leverages 3D printing, DNA concentration...
This Project Grant award from the National Science Foundation (CFDA 47.041 - Engineering) totaling $1,400,000 aims to advance the manufacturing of ultra-high-density, DNA-enabled nanoelectronics systems. The key goals are to: Develop scalable methods for obtaining high-purity carbon nanotubes, self-aligned single-molecule junctions, and hybrid DNA nanostructures. Establish reliable processes for integrating bottom-up and top-down architectures using field-driven directed assembly and...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $274,932 to Femtofluidics Incorporated to develop hardware that can rapidly and inexpensively synthesize DNA-encoded libraries (DELs) for drug discovery. The project aims to create an electronic device that can manipulate nanoliter to picoliter volume droplets to perform combinatorial chemistry, overcoming limitations of traditional liquid-handling robots. This technology...
This Project Grant award from the National Institutes of Health's National Human Genome Research Institute provided $768,678 to Molecular Assemblies, Inc. to develop a fully enzymatic oligonucleotide synthesis cycle using engineered template-independent polymerases and a novel phosphate dNTP blocking group. The award supports the goals of the Human Genome Research program (CFDA 93.172) to accelerate genome research and its application to human health. Specifically, the awardee will engineer...
This $600,000 Project Grant from the National Science Foundation's Computer and Information Science and Engineering program will fund research at the University of Texas at Austin to develop DNA-based storage and computation techniques. Specifically, the award supports the creation of a "SIMD-DNA" paradigm that uses strand displacement reactions to manipulate digital data encoded in the topological structure of DNA. This approach aims to enable parallel, in-memory computation...
This $300,000 Project Grant award from the National Science Foundation's (NSF) Integrative Activities (CFDA 47.083) program supports research and development at the University of New Mexico (UNM) focused on computational modeling and experimental validation of DNA nanodevices. The project aims to advance simulation-guided design of DNA-based molecular systems for potential biomedical applications such as in-vivo diagnostics. Key activities include integrating high-level and low-level...
This Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) provides $300,000 to the Massachusetts Institute of Technology (MIT) to develop a novel biological computing platform based on programmable DNA molecules. The project aims to explore the limits of data storage and computing capabilities of individual DNA templates and their spatial patterns across large-scale surfaces. Key goals include increasing...
The National Institute of General Medical Sciences (NIGMS) awarded a $300,518 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to E&E Bioclub LLC in Indianapolis, IN. The purpose of this 1-year grant, from Sep 1, 2024 to Aug 31, 2025, is to develop an all-in-one platform for intracellular overproduction of long, single-strand mRNA. This addresses challenges in current mRNA manufacturing approaches, which are constrained by high costs, lack of...
This $325,000 project grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will support the development and testing of a new class of programmable, non-viral gene therapy carriers and cargo known as virus-inspired DNA origami (VIDO) vectors and repair templates. The project aims to demonstrate that VIDO vectors can effectively encapsulate and co-deliver CRISPR-Cas9 gene editing agents and repair...

This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), aims to develop a new, highly automated, and low-cost method for producing long synthetic DNA molecules. The $295,923 award to Avery Digital Data, Inc. will fund research into using electronic nanochannel chip devices to precisely control the motion of DNA fragments and enable the assembly of longer, gene-length DNA constructs. This innovation could dramatically increase the availability of large DNA sequences for advanced genetic engineering applications in biomedical research, such as installing complex synthetic pathways in engineered cells or delivering more comprehensive payloads in mRNA vaccines. The project will run from May 1, 2024 to April 30, 2025, with the goal of enabling the future fabrication of CMOS chip devices optimized for scalable, low-cost production of designer long DNA.

Generated 4/8/25, 5:41 AM